Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Hims & Hers Health Inc (NYSE: HIMS) was $31.54 for the day, up 3.38% from the previous closing price of $30.51. In other words, the price has increased by $3.38 from its previous closing price. On the day, 7.66 million shares were traded. HIMS stock price reached its highest trading level at $32.73 during the session, while it also had its lowest trading level at $30.35.
Ratios:
Our analysis of HIMS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 27.12 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 46.06. For the most recent quarter (mrq), Quick Ratio is recorded 1.82 and its Current Ratio is at 2.14. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Citigroup on January 10, 2025, Downgraded its rating to Sell and sets its target price to $25 from $24 previously.
On January 07, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.
On December 17, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $42.Morgan Stanley initiated its Overweight rating on December 17, 2024, with a $42 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 24 ’25 when Chi Michael sold 17,304 shares for $31.00 per share. The transaction valued at 536,424 led to the insider holds 193,601 shares of the business.
Dudum Andrew sold 27,098 shares of HIMS for $815,029 on Jan 23 ’25. The Chief Executive Officer now owns 27,918 shares after completing the transaction at $30.08 per share. On Jan 24 ’25, another insider, Chi Michael, who serves as the Officer of the company, bought 17,304 shares for $31.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 6890828288 and an Enterprise Value of 6648118272. As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 72.96, and their Forward P/E ratio for the next fiscal year is 60.49. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.55 while its Price-to-Book (P/B) ratio in mrq is 15.61. Its current Enterprise Value per Revenue stands at 5.353 whereas that against EBITDA is 111.318.
Stock Price History:
The Beta on a monthly basis for HIMS is 1.32, which has changed by 2.555944 over the last 52 weeks, in comparison to a change of 0.25219524 over the same period for the S&P500. Over the past 52 weeks, HIMS has reached a high of $35.02, while it has fallen to a 52-week low of $8.51. The 50-Day Moving Average of the stock is 12.24%, while the 200-Day Moving Average is calculated to be 52.48%.
Shares Statistics:
HIMS traded an average of 16.42M shares per day over the past three months and 10687690 shares per day over the past ten days. A total of 209.44M shares are outstanding, with a floating share count of 177.52M. Insiders hold about 18.75% of the company’s shares, while institutions hold 56.27% stake in the company. Shares short for HIMS as of 1736899200 were 56576887 with a Short Ratio of 3.45, compared to 1734048000 on 42972111. Therefore, it implies a Short% of Shares Outstanding of 56576887 and a Short% of Float of 29.5.
